HEDIMED

The HEDIMED project aims to identify the environmental causes behind type 1 diabetes, celiac disease, allergies and asthma.

The HEDIMED Mission

The mission of HEDIMED is to find out prevention for immune-mediated diseases, including  type 1 diabetes, celiac disease, asthma and allergies. This will be accomplished by identifying the environmental exposures contributing to the development of these diseases.

HEDIMED Partners

Research

HEDIMED brings together data and biological samples from 17 human cohorts. These cohorts come from high and low-risk countries of immune-mediated diseases. The project consists of 13 work packages that will generate new knowledge about the causes of these diseases by exploring the role of the environment, using the latest technologies developed by the 22 partners.

HEDIMED project complies with international conventions and codes of conduct in its research activities, and EU regulations, including GDPR, will be followed in the consortium.

The European Exposome Network

The European Human Exposome Network is the world’s largest network consisting of nine projects studying the impact of environmental exposure on human health, funded by the European Union.

News

HEDIMED kickoff

HEDIMED kickoff took place in Tampere in February 2020 with all 22 partners present

Read more… 

HEDIMED kickoff

HEDIMED kickoff took place in Tampere in February 2020 with all 22 partners present

Read more… 

EHEN launch

HEDIMED was introduced along with the other projects of the Human Exposome Network at the European Commission in Brussels in February 2020.

Read more… 

EHEN launch

HEDIMED was introduced along with the other projects of the Human Exposome Network at the European Commission in Brussels in February 2020.

Read more…